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Abstract: 
The interactions of 2-ethoxy(4H)-3,1-benzoxazin-4-one (1) with various nitrogen nucleophiles such as 
ammonium acetate,  hydrazine hydrate, ethanolamine, p-phenylenediamine, o-phenylenediamine, o-
tolidine, dapsone, 2-aminophenol, 4-aminophenol, 4-aminobenzoic acid and 2-aminonicotinic acid have 
been discussed. The reactions of 2-thoxy-(3H)-quinazolin-4-one with ethyl chloroformate, phosphorus 
pentasulfide, chloroacetyl chloride and phosphorus oxychloride have also been investigated. Similar 
reactions of 2-ethoxy-4-chloroquinazoline with hydrazine hydrate and thiosemicarbazide have been 
introduced. Aminolysis of the 2-ethoxy group in some of the thiadiazoloquinazolinone derivatives has been 
attempted. The interactions of these aminolized derivatives and the 3-aminoquinazolinone with 
chloroacetyl chloride have been studied. All of the synthesized derivatives have been used in a wide range 
as starting materials for the synthesis of novel quinazoline and/or quinazolinones which have biological 
activity. The structures of all these products, obtained by heterocyclic ring opening and ring closure, were 
inferred by the IR, MS, 
1
H NMR spectral as well as elemental analyses. 
Keywords: Aminothiadiazole, Benzoxazin-4-one, N-nucleophile, quinazoline, quinazolin-4-one, 
thiosemicarbazide.  
 
1. Introduction 
3,1-Benzoxazin-4-ones can be considered as semiacid anhydrides which undergo many of the reactions  of
 
 
true acid anhydrides,  but at a slower rate.  This special reactivity allows this class of compounds
 
 to be  
useful as antimicrobial (Mathew et al 2010), anti-platelet aggregation (Pritchard et al 2007), human 
leukocyte elastase inhibitors (Pei-Wen Hsieh et al 2005),  receptor  agonist active (Ward et al 2007), 
receptor  antagonist  active (Deswal et al 2006, ohno et al 2006, Kern et al 2007, Powell et al 2007, 
Bromidge et al 2009), pesticides (Shakil et al 2010), tissue  culture protective  and
 
 in vivo
 
  model of 
neurodegeneration (Wang et al 2010) and improve
 
 the umbilical vein endothelial cells (Dong et al 2010). 
On the other hand, in recent years, there has been an increasing interest in the chemistry of 4(3H)-
quinazolinones because of their biological importance. Many of them show antifungal (Bartroli et al 1998), 
antibacterial (Shiba et al 1997), anticancer (Abdel-Hamid et al 1997), anti-inflammatory (Barker 1995), 
anticonvulsant (Bekhit et al 1998),  immunotropic (Gursoy et al 1995), hypolipidemic (Nawrocka et al 
1997),  antitumor (Kurogi et al 1996), antiulcer (Hame et al 1996), analgesic (Terashima et al 1995),  
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antiproliferative activities (Raffa et al 1999)  and  inhibitory effects (Baek et al 1998)  for thymidylate  
synthase  and poly(ADP-ribose)  polymerase (PARP) (Griffin et al 1998).  The
 
4(3H)-quinazolinones
 
 can
 
 
act
 
 as semicyclic amides or iminols, due to
 
 the
 
 tautomeric
 
 phenomenon
 
 they have. Their
 
 reactions in 
either form with alkyl or acyl halides  are perhaps the most interesting due to  the  large  number  of  
heterocycles  that  are obtained  either  directly  or through  further  transformations  of  the  initially  
formed  products. Also quinazolines are a big family of
 
 heterocyclic compounds, which have shown broad 
variety of biological activity profiles (Jhone 1982, Brown 1996), e. g. analgesic, narcotic, diuretic, 
antihypertensive, antimalarial, sedative,  hypoglycaemic,
 
 antibiotic,
  
antitumoral
  
and  many others. It has 
been found (Armarego 1967)  that the biological  activity  strongly depends on the type and place of the 
substituents in their  molecules. Out of the wide substitution  patterns known,
 
4-aminoquinazolines are  
useful as fungicides (Nakagami et al 1982, Haley 1994) anti-inflammatory (Palanki et al 1999, Myers et al 
1998) anticancer (Baker 1999)  anti-microbial  and   anti-hypertensive
 
  agents (Nauta 1976, Mizogami et al 
1986).
      
Some  4-anilinoquinazolines
 
 have found to be potential and highly selective  inhibitors of human 
immunoglobulin E
 
(Berger et al 2001) and
 
epidermal growth
 
factor receptor tyrosine kinase
 
(Bridges 2001) 
which regulates the  cell  growth  and  proliferation,  so  they  work  as  potent  antiallergic  or  anticancer  
agents, respectively. 
 
Among the broad synthetic pathways for aminoquinazoline preparation (Katritzky et 
al 1996 and 2000)
 
 the  substitution of chlorine  atom in 4-chloroquinazolines by amines is the shortest and 
cheapest one. On the other hand, it is well known that heterocycle-bearing N-glycosides
  
play a significant  
role  as inhibitors, e. g. the tetrazole-bearing
 
 N-glycosides
 
 used
 
 as SGLT2 inhibitors (Gao et al 2010) 
where their  hypoglycemic activity is tested in vivo by mice oral glucose tolerance test (OGTT). In the 
current article we report the synthesis of 4-aminoquinazoline-bearing N-glycosides in a similar way with 
exception of the endocyclic 2° nitrogen atom attached to the glucose moiety. 
 
2. Results and Discussion 
In this paper we used the 2-ethoxy(4H)-3,1-benzoxazin-4-one (1) to synthesize novel quinazoline and 
quinazolinone derivatives having active functional groups which make their parent compounds important to 
be used as starting materials for novel derivatives. This advantage will be revealed by the functional group 
(or groups) residing on position 2 of the benzoxazinone ring, on positions 2 and 3 of the quinazolin-4-one 
ring and positions 2 and 4 of the quinazoline ring.   Thus, the fusion of compound 1 with ammonium 
acetate gave the quinazolin-4-one 4 (Scheme 1). 
OEt
O
NH
NOEt
O
O
N
1 2
Scheme  1  : synthetic pathway for compound  2
NH4OAc
oil bath, 190
o
C, 2 h
 
 
The structure of compound 2 was inferred by its 
1
H NMR spectrum that showed a singlet at  δ  12.30 which 
is attributable for NH group. 
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Compound 1 reacted with hydrazine hydrate in boiling ethanol to give 3-aminoquinazolinone 3 (Scheme 2). 
OEt
O
N
N
NH2
OEt
O
O
N
1 3
Scheme  2 : synthetic pathway for compound  3
N2H4 . H2O 
Reflux, ethanol, 2 h
 
 
The structure of compound 3 was assigned by its 
1H NMR spectrum that showed a singlet at δ 2.00 which 
is attributable for amino group. 
 
Compound 1 was interacted with 2-aminoethanol in boiling ethanol to afford compound 4 which
 
on
 
heating 
above its melting point (120-121 ºC) yielded the desired product 4a (Scheme 3). 
 
OEt
O
O
N
H2NCH2CH2OH
OEt
O
N
N
OH
1 4a
H
H
N-CH2CH2OH
OEt
COO
-
N
+
4, amidine salt
- H2O
Scheme 3: Synthetic pathway for compounds 4 and 4a
Reflux, ethanol, 3 h
 
The elemental analyses and spectroscopic data for 4 and 4a were consistent with the assigned structures
 
and  
isolation of 4 ruled out an abnormal nucleophilic addition to  C-2 to form an amidine salt  that subsequently 
dehydrates to give the desired product 4a (Dong et al 2010). 
Compound 1 was reacted with p-phenylenediamine in boiling ethanol affording compound 5 (Scheme 4). 
OEt
O
N
N
NH2
OEt
O
O
N
1 5
Scheme  4 : synthetic pathway for compound  5
Reflux, ethanol, 2 h
NH2 NH2
 
The structure of 5 was confirmed by microanalytical and spectral analysis.  
Compound 1 was reacted with o-phenylenediamine in warming ethanol affording compound 6 (Scheme 5). 
Heating compound 6 above its melting point afforded compound 6a with traces of compound 6b.  
OEt
O
N
N
NH2
OEt
O
O
N
1 6
Scheme  5 : synthetic pathway for compounds  6, 6a and 6b 
Warming, ethanol
NH2
NH2
15 minutes
Reflux, 3 h
6a
OEt
N
N
N
NH
O
N
N
+
6b
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The 
1
H NMR spectrum of 6a devoid any band for the carbonyl group whereas the 
1
H NMR of 6b devoid 
any band for the ethoxy group.     
Compound 1 was reacted with o-tolidine in boiling ethanol to give compound 7 (Scheme 6).  
OEt
O
O
N
Scheme  6 : synthetic pathway for compound  7
Reflux, ethanol, 3 h
71
CH3 CH3
NH2 NH2
N
N
O
OEt
NH2
CH3
CH3
 
The structure of compound 7 was assigned by its mass spectrum and elemental analysis. 
Compound 1 was reacted with dapsone in boiling ethanol to give compound 8 (Scheme 7). 
OEt
O
O
N
Scheme  7 : synthetic pathway for compound  8
Reflux, ethanol, 3 h
N
N
O
OEt
S
O
O
NH2
S
O
O
NH2 NH2
81
 
The structure of compound 8 was assigned by its mass spectrum and elemental analysis. 
Compound 1 was reacted with 2-aminophenol in boiling ethanol to give compound 9 (Scheme 8). 
OEt
O
N
N
OH
OEt
O
O
N
1 9
Scheme  8 : synthetic pathway for compounds  9
NH2
OH
Reflux, 3 h
 
Compound 1 was reacted with 4-aminophenol in boiling ethanol to give compound 10 (Scheme 9). 
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OEt
O
N
N
OH
OEt
O
O
N
1 10
Scheme  9 : synthetic pathway for compounds  10
OHNH2
Reflux, 3 h
 
The structures of compounds 9 and 10 were confirmed by microanalytical and spectral analysis.  
Compound 1 was reacted with 4-aminobenzoic acid in boiling ethanol to give compound 11 (Scheme 10). 
OEt
O
N
N
COOH
OEt
O
O
N
1 11
Scheme  10 : synthetic pathway for compounds  11
COOHNH2
Reflux, 3 h
 
Compound 1 was reacted with 2-aminonicotinic acid in boiling ethanol to give compound 12 (Scheme 11). 
OEt
O
N
N
N
HOOC
OEt
O
O
N
1 12
Scheme  11 : synthetic pathway for compounds  12
Reflux, 3 h
N NH2
COOH
 
The structures of products 11 and 12 were inferred by microanalytical and spectral analysis. The IR
 
spectra 
for 11 and 12
  
showed absorption bands in the range
 
1704-1705 attributable to υmax  of
 
 C=O
 
groups of acids.
  
  
Compound 2 was reacted with ethyl chloroformate in dry pyridine to give compound 13 (Scheme 12). 
OEt
O
NH
N
2 13
Scheme  12 : synthetic pathway for compounds  13
OEt
O
N
N
O
OEtClCOOEt
Pyridine/ 0
o
C
 
The IR spectrum devoid any band of NH but rather revealed an absorption band at 1762 attributable to υmax  
of
 
 C=O
 
group of ester. 
Compound 2 was reacted with phosphorus pentasulfide in dry xylene to give compound 14 (Scheme 13).  
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OEt
O
NH
N
2 14
Scheme  13 : synthetic pathway for compounds  14
OEt
S
NH
N
P2S5
Xylene/ reflux 8 h
 
The IR spectrum devoid any band of C=O in the carbonyl region but rather revealed an absorption band at 
1319 attributable to υmax  of
 
 C=S
 
group. 
Compound 2 was reacted with phosphorus oxychloride in water bath to give compound 15 (Scheme 14). 
OEt
O
NH
N
2 15
Scheme  14 : synthetic pathway for compounds  15
OEt
Cl
N
N
POCl3
water bath/ 3 h
 
The IR spectrum devoid any band of C=O in the carbonyl region.  
Compound 15 was reacted with hydrazine hydrate in boiling ethanol to give compound 16 (Scheme 15).  
OEt
Cl
N
N
15 16
Scheme  15 : synthetic pathway for compounds  16
OEt
NH
N
N
NH2
N2H4 . H2O
Ethanol / reflux, 3 h
 
The IR spectrum revealed an absorption band in the range 3250-3300 attributable to υmax  of
 
 NH2 
 
group. 
Compound 15 was heated with thiosemicarbazide in AcOH / fused NaOAc to give product 17 (Scheme 16).  
OEt
Cl
N
N
15 17
Scheme  16 : synthetic pathway for compounds  17
OEt
NH
N
N
S
NH
NH2
Acetic acid/ reflux, 3h
H2NC(S)NHNH 2
 
The IR spectrum revealed an absorption band at 1381 attributable to υmax of
 
 C=S
 
group. 
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Compound 1 was heated with thiadiazole derivatives in boiling AcOH/fused NaOAc affording compounds 
18a-c (Scheme 17). 
 -CH2 N
O
O1
RS
N N
NH2 OCH2CH3
O
N
N
RS
N N
AcOH
fused NaOAc
18b : R =   -CH=CH - C6H5
18a :  R =   - C6H5
18c :  R =     
18a - c
Scheme  17 : synthetic pathway for compounds    18a-c
+
OEt
O
O
N
 
The structures of 18a-c were assigned by their mass spectra and elemental analysis. 
Compounds 18a-c were fused with ammonium acetate or formamide to give products 19a-c (Scheme 18). 
OEt
O
N
N
RS
N N
18a - c
Scheme  18 : synthetic pathway for compounds    19a-c
HCONH2
fusion / 2 h
NH2
O
N
N
RS
N N
19a-c
 -CH2 N
O
O
19b : R =   -CH=CH - C6H5
19a :  R =   - C6H5
19c :  R =    
 
The 
1
H NMR spectrum devoid any band of ethoxy group. 
Compounds 19a-c were reacted with chloroacetyl chloride in pyridine to give products 20a-c (Scheme 19). 
NH2
O
N
N
RS
N N
19a - c
Scheme  19 : synthetic pathway for compounds    20a-c
Pyridine
stiring at r.t.
NH
O
N
N
RS
N N
O
Cl
20a-c
 -CH2 N
O
O
20b : R =   -CH=CH - C 6H5
20a :  R =   - C 6H5
20c :  R =    
ClCH2COCl
 
Compound 3 was reacted with chloroacetyl chloride in pyridine to give compound 21 (Scheme 20). 
OEt
O
N
N
NH O
ClOEt
O
N
N
NH2
3 21
Scheme  20 : synthetic pathway for compound  21
Pyridine / r.t.
ClCH2COCl
 
The 
1
H NMR spectra for 20 and 21 always revealed singlets at δ 8.00 and 8.11 for the amidicNH. 
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Experimental    
All  melting points  recorded  are  uncorrected.  The IR   spectra 
 
 were  recorded  on  a Pye Unicam SP1200  
spectrophotometer using KBr wafer technique.
 
The
  1
H-NMR spectra were determined
  
on 
 
a Varian FT-200,  
Brucker AC-200 MHz spectrophotometry  experiment using TMS as  an  internal standard.  Chemical shifts 
(δ)  are  expressed  in  ppm. The mass spectra were determined  using MP  model  NS-5988  and  Shimadzu 
single focusing mass spectrometer (70 eV). 
The 2-ethoxy(4H) –3,1–benzoxazin–4–one 1 was  prepared according  to  methods available in the literature 
(Krantz et al 1990) and was immediately used after preparation, prior to each synthesis  to avoid moisture. 
 
2- Ethoxy-4(3H)quinazolinone  2.    2-ethoxy(4H)-3,1-benzoxazin-4-one (0.01 mol) and ammonium acetate 
(0.01 mol) were fused  using an oil bath for 2 h. The mixture was poured  into  an  ice / water  mixture  and  
stirred. 
 
 The yellowish white precipitate that separated out was filtered, washed, dried, and then crystallized 
from ethanol to give off-white crystals of compound 2. M.p. 155-156ºC;  yield 85 %; Anal. for
 
 C10H10N2O2  
(m.wt. 190);  Found:  C, 63.16;  H, 5.26; N, 14.74;  Calcd: 
 
C, 63.22;  H, 5.18;  N, 14.72;  IR  υ  (cm-1) 1671 
(C=O), 3229 (NH); MS: m/z (int. %) [M+H]+ 190 (58%); 
1
H-NMR (DMSO-d6)  δ 1.19 (t, 3H; OCH2CH3, J 
= 7.4 Hz), 4.29 (q, 2H; OCH2CH3,   J = 7.4 Hz), 7.31-8.17 (4d, 4H; ArH), 12.30 (br s, 1H, NH). 
3-Amino-2-ethoxyquinazolin-4(3H)-one    3.   2-ethoxy-4H-3,1- benzoxazin-4-one  (0.01  mol)  was  heated 
under reflux with hydrazine hydrate (0.02 mol) in ethanol (20 mL) for 3 h. The mixture was cooled, filtered 
off and crystallized from ethanol as off-white needles;  yield
  
68 %; m.p.
 
172-173 °C.  Anal. for C10H11N3O2 
(m.w.  205);  Found:  C, 58.59;  H, 5.42;
 
 N, 20.56;  Calcd:  C, 58.53;  H, 5.37;  N, 20.49;  IR υ  (cm-1) 1671 
(C=O), 1528 (C=N); 3389 (NH); 3443 (CH);
 
 MS: m/z (int. %) [M+H]
+  
205 
 
(78.3); 
1
H-NMR (DMSO-d6)
 δ 
1.14 (t,
 
3H;
 
OCH2CH3),
 
4.33
 
(q, 2H; OCH2CH3),
 
7.29-8.19
 
(m, 4H;
 
ArH),
 
2.0 (s, NH,
 
amine). 
Synthesis of Compounds 4 and 4a 
A mixture of compound 1 and ethanolamine (0.01mol each) in boiling ethanol (30 mL)
 
was refluxed for 3h. 
Concentration of the solvent left a white precipitate of compound  4  which was crystallized from ethanol to 
affording off-white crystals. Heating of 4 above its  melting  point yielded  the
 
 corresponding  product 4a.   
2-Ethoxycarbonylamino(β-hydroxyethyl)benzamide 4. Yellowish white crystals from ethanol;  m.p. 120-121 
ºC; yield  80 %; Anal.  for  C12H16N2O4  (m.w. 252);  Found: C, 57.21;  H, 6.29;  N, 11.13;  Calcd: C, 57.14; 
H, 6.35; N, 11.11; IR υ  (cm-1) 1636 (C=O), 1737 (C=O), 3069 (CH), 3130 (NH), 3342 (OH);  MS: m/z (int. 
%) [M+H]+  252 (42.3). 
2-Ethoxy–3-(2-hydroxyethyl)quinazolin–4–one 4a. 
Light brown crystals;  m.p. 108-109 ºC; yield 75 %; Anal. for C12H14N2O3  (m.w. 234);  Found: C, 61.05; H, 
5.98; N, 12.03; Calcd:  C, 61.54;  H, 5.98; N, 11.97; IR υ  (cm-1) 1660 (C=O), 3340 (OH).  MS: m/z (int. %) 
[M+H]+ 234 (58.0), 236 (12.8), 190 (100), 192 (22.3); 174 (22.3), 176 (12.4);  
1
H-NMR (DMSO-d6)  δ 1.19 
(t, 3H; OCH2CH3, J
 
 = 7.4 Hz), 3.52 (m, 2H, 2'-H), 4.32 (q, 2H; OCH2CH3,  J  = 7.4Hz), 4.13 (m, 1H, 1'-H), 
5.72  (s, br., OH), 7.41- 8.16  (4 d, 4H; ArH). 
2-Ethoxy-3-(4-aminophenyl)quinazolin-4-one  5.     A  mixture of compound 1 (0.01 mol) and  p-phenylene 
diamine (0.01 mol)
 
 in
  
boiling
 
 ethanol (30 mL) was refluxed for 3 h.   Concentration of
 
 the
 
 solution gave a 
solid which was filtered, washed, dried
 
and then crystallized from ethanol to give blue crystals of product 5; 
m.p. 105-106 ºC; yield 80 %. Anal. for C16H12N3O2  (m.w. 278); Found: C, 69.22; H, 4.16; N, 15.08; Calcd:  
C,
 
 69.06; H, 4.32;
 
 N, 15.10;  IR υ  (cm-1) 1635 (C=N), 1670 (C=O), 3225 (NH).  MS: m/z  (int. %) [M+H]+ 
278  (55.0), 280  (18.2), 191 (100), 193 (31.7), 175 (32.1), 177 (0.8), 157  (4.7), 159  (0.6), 130  (52.4), 132 
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(0.3), 93 (0.9), 95 (0.1), 78 (0.2), 80 (0.1); 
1
H-NMR (DMSO-d6) δ 1.22 (t, 3H; OCH2CH3, J
 
 = 6.9 Hz), 4.35 
(q, 2H; OCH2CH3  J = 6.9Hz), 5.12 (s, 2H, NH2), 6.70-7.43 (m, 4H; Ph-H), 7.47-8.19 (m, 4H, quinazolone). 
Reactions of Compound 1 with o-phenylene diamine: 
A mixture of compound 1
 
and o-phenylenediamine (0.01
 
mol each) was slightly warmed in ethanol (30 mL) 
for 15 min.  The precipitate that separated out was filtered, washed, dried
 
and then crystallized from ethanol 
to give light blue crystals of product 6.  Heating product 6 above its melting point gave dark blue residue of 
unstable melting point.  Crystallization of the residue, using different ratios of benzene/ethanol, enabled the 
products 6a and 6b to be isolated. The purity of products was checked by different melting points and TLC.      
3-(2-aminophenyl)-2-ethoxyquinazolin-4(3H)-one    6.   M.p. 105-106 ºC; yield 80 %. Anal. for C16H12N3O2  
(m.w. 278);  Found:  C, 69.22;  H, 4.16;  N, 15.08;  Calcd:  C, 69.06;  H, 4.32;  N, 15.10;  IR  υ  (cm-1) 1635 
(C=N),  1670 (C=O),  3225 (NH).  MS: m/z  (int. %)  [M+H]+ 278 (55.0), 280 (18.2), 191 (100), 193 (31.7), 
175 (32.1), 177 (0.8), 157  (4.7), 159  (0.6),  130  (52.4), 132 (0.3), 93 (0.9), 95 (0.1), 78 (0.2), 80 (0.1); 
1
H-
NMR (DMSO-d6)  δ  1.22 (t, 3H; OCH2CH3,   J
 
 = 6.9 Hz), 4.36 (q, 2H; OCH2CH3  J = 6.9 Hz), 5.24 (s, 2H, 
NH2), 6.71-7.42 (m, 4H; Ph-H), 7.29-8.19 (m, 4H, quinazolinone). 
2-Ethoxy benzimidazolo-[1,2-c]quinazoline 6a. M.p. 191-192 ºC; yield 85 %. Anal.  for  C16H13N3O    (m.w.  
263); Found: C, 73.02;  H, 4.94; N, 15.98; Calcd: C, 73.00; H, 4.94; N,15.97;  IR υ (cm-1) 1607 (C=N). MS: 
m/z (int. %) [M+H]+ 263 (66.0), 265 (17.3),  187 (44.8),  189 (4.8),  175 (28.4),  177 (11.1),  157 (3.3),  159 
(0.1), 130 (78.9), 132 (12.4), 78 (2.4), 80 (0.1);  
1
H-NMR  (DMSO-d6)  δ  1.22 (t, 3H;  -OCH2CH3,  J
 
 = 7.1 
Hz), 4.31 (q, 2H; OCH2CH3  J  = 7.1),
 
7.52-7.92 (m, 4H, benzimidazole),
 
7.62-8.55 (2m, 4H; quinazoline). 
Benzimidazo[2,1-b]quinazolin-5(1H)-one  6b.   M.p. 202-203 ºC;  yield 23 %. Anal.  for  C14H9N3O    (m.w.  
235); Found: C, 71.56;  H, 3.85; N, 17.91; Calcd: C, 71.49; H, 3.83; N, 17.87; IR υ (cm-1) 1607 (C=N). MS: 
m/z (int. %) [M+H]+ 235 (26.0), 237 (1.8);  
1
H-NMR (DMSO-d6)  δ 7.52-7.92 (m, 4H, PhH),
 
7.62-8.55 (2m, 
4H; quinazoline), 6.88 (br s, 1 H, NH). 
2-Ethoxy-3-(3,3'-dimethyl-4-amino)biphenyl quinazolin-4-one    7. 
 
 A mixture of benzoxazinone 1 and 3,3'-
dimethyl-4,4'-biphenyldiamine (0.01 mol each)  in boiling butanol (30 mL) was heated under reflux for 6 h. 
The solvent was concentrated leaving a solid gum which was washed, filtered,  dried
 
and then recrystallized 
from ethanol giving product 7 as dark brown crystals;  m.p. 121-122 ºC; yield 80 %;  Anal. for  C24H23N3O2  
(m.w. 385);  Found:  C, 74.53;  H, 5.63;  N, 10.79;  Calcd:  C, 74.80;  H, 5.97;  N, 10.90;  IR  υ  (cm-1) 1620 
(C=N), 1675 (C=O),  3250 (NH).  MS: m/z (int. %) [M+H]+   385 (72.0),  387 (34.2),  228 (13.3),  230 (1.2),  
198 (12.7),  200 (0.1),  194 (16.1),  196 (0.4),  191 (100),  193 (24.8),  175 (53.3),  177 (8.7), 157 (7.1), 159 
(1.4),  154 (1.2),  156 (0.2), 
 
130 (46.3), 
 
132 (0.1),  78 (0.3),  80 (0.1);  
1
H-NMR (DMSO-d6)  δ 1.22 (t, 3H; 
-OCH2CH3,  J
 
 = 6.9 Hz),  2.21- 2.29 (s,
 
 6H; 2ArCH3),  4.40 (q, 2H;  -OCH2CH3  J  = 6.9 Hz),  5.08 (2H,
 
 s, 
NH2), 6.90-7.80 (m, 6H; biphenyl-H), 7.33-8.19 (m, 4H, quinazolinone). 
3-[4-(4-aminobenzenesulfonyl)phenyl]-2-ethoxyquinazolin-4(3H)-one 8.   Benzoxazinone 1 (0.01 mol) was 
dissolved in 20 ml of ethanol and then dapsone (0.03 mol) was added to it. The mixture was refluxed for 4h 
and cooled. The separated solid 8 was crystallized from ethanol as colorless crystals; m.p. 144-146oC; yield 
61%; Anal. For C22H19N3O4S (m.w. 421); Found: C, 62.77; H, 4.53; N, 99. 86; Calcd: C, 62.71; H, 4.51; N, 
99.77; IR υ (cm-1) 1162 (S=O), 1631 (C=N), 1764 (C=O), 3230 (NH). MS: m/z (int. %) [M+H]+ 421 (12.0); 
119 (100); 
1
H-NMR (DMSO-d6)  δ 1.22 (t, 3H; -OCH2CH3,  J
 
 = 6.9 Hz),  4.47 (q, 2H;  -OCH2CH3  J  = 6.9 
Hz),  5.08 (2H,
 
 s, NH2), 7.30-8.20 (m, 4H, quinazolinone), 7.22-8.35 (m, 8H; Ar-H). 
Synthesis of compounds 9 and 10 
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A mixture of compound  1 and  o-hydroxyaniline or p-hydroxyaniline (0.01 mol each)  in 40 mL of boiling 
ethanol was
 
 refluxed for 3 h. The obtained  precipitate  was heated in  a
 
 round bottom flask (25 mL) in  an 
oil  bath  at  160 ºC  for  30
 
 minutes.    After  cooling  the  products  were  crystallized  from   the   proper   
solvent  to  give  the  corresponding  quinazolinones 9 and 10,  respectively. 
2-Ethoxy-3-(2-hydroxyphenyl)quinazolin-4-one 9.   Dark brown crystals from light petroleum (100-120 ºC);  
m.p.  89-90 ºC; yield 80 %;  Anal. for C16H14N2O3   (m.w. 284);  Found:  C, 67.31;  H, 4.73; N, 9.89;  Calcd: 
C, 67.60; H, 4.93; N, 9.86; IR υ  (cm-1) 1669 (C=O), 2988 (OH);  MS: m/z (int. %) [M+H]+ 284 (48.0),  286  
(6.3),  191 (100),  193  (43.3),  175 (18.2),  177 (0.1),  157 (4.7),  159 (1.2),  130 (67.1), 132 (6.3); 
1
H-NMR 
(DMSO-d6)  δ 1.22 (t, 3H; -OCH2CH3, J
 
 = 7.4 Hz), 4.36 (q, 2H;  -OCH2CH3  J  = 7.4 Hz),  5.55 (s, H; OH), 
6.76 – 7.67 (m, 4H; Ph-H), 7.30 – 8.19 (m, 4H, quinazolinone). 
2-Ethoxy-3-(4-hydroxyphenyl)quinazolin-4-one 10.   Dark brown crystals from benzene;   m.p. 105-106 ºC; 
yield 80 %; Anal. for C16H14N2O3  (m.w. 284);  Found: C, 67.42; H, 4.70; N, 9.81; Calcd: C, 67.60; H, 4.93; 
N, 9.86;  IR  υ (cm-1) 1671(C=O), 2992 (OH);   MS: m/z (int. %) [M+H]+ 284 (43.0),  286 (16.3), 191 (100), 
193 (52.3), 175 (20.8), 177 (0.1), 157 (4.3), 159 (0.5),
 
 130 (57.4), 132 (7.9);  
1
H-NMR   (DMSO-d6)  δ 1.22 
(t, 3H; -OCH2CH3, J
 
 = 7.4 Hz),  4.35 (q, 2H;  -OCH2CH3  J  = 7.4 Hz),
 
 5.35 (s, H; OH),  6.68-7.69 (m, 4H; 
Ph-H), 7.43–8.19 (m, 4H, quinazolinone). 
4-[2-Ethoxy-4-quinazolon-3-yl]benzoic acid
 
 11.  A mixture of compound 1 (0.01 mol) and p-aminobenzoic  
acid in boiling butanol (30 mL) was refluxed for 3 h.  Concentration of
 
 the
 
 solution gave a solid which was 
washed, filtered, dried
 
and then crystallized from ethanol affording derivatives 11 as light brown crystals of   
m.p. 151-152 ºC;  yield 80 %; Anal. for C17H14N2O4  (m. w. 310); Found: C, 65.44; H, 4.72; N, 9.00; Calcd:  
C, 65.80; H, 4.52; N, 9.03; IR υ (cm-1) 1675, 1705 (2xC=O), 3355 (chelated OH); MS: m/z (int. %) [M+H]+  
310 (63.0),  312 (28.2),  191 (100),  193 (27.8),  175 (34.3),  177 (0.6), 130 (59.3), 132 (0.2), 122 (1.8), 124 
(0.2), 78 (0.1), 80 (0.1); 
1
H-NMR (DMSO-d6) δ 1.22 (t, 3H; OCH2CH3, J
 
 = 6.9Hz), 4.36 (q, 2H;OCH2CH3,  
J  = 6.9 Hz), 7.40-8.00 (m, 4H; PhH), 7.43-8.19 (m, 4H, quinazolinone), 10.6 (1H, acid proton).  
2-[2-Ethoxy-4-oxoquinazolin-384H)-yl]pyridine-3-caboxylic
 
acid
 
 12.  A mixture of benzoxazinone  1 (0.01 
mol) and 2–aminonicotinic acid (0.01 mol) in boiling butanol (30 mL) was refluxed for 6 h.   Concentrating 
the
 
 solution gave a solid which was washed, filtered, dried
 
and then crystallized from ethanol affording  the   
quinazolinone 12 as brown crystals; m.p. 298-300ºC; yield 80 %; Anal. for C16H13N3O4  (m.w. 311); Found: 
C,
 
 61.58;  H, 4.26; N, 13.20; Calcd: C, 61.74; H, 4.18; N,  13.50;  IR  υ (cm-1) 1669, 1704  (2xC=O),  3255  
(chelated  OH);  MS: m/z  (int. %) [M+H]+   311 (36.0),  313 (19.5),  191 (100),  193 (28.6),  175 (61.8), 177 
(7.6), 157 (5.2), 159 (1.1), 130 (58.2), 132 (0.6), 123 (0.7), 125 (0.2), 79 (0.7), 81 (0.1) ; 
 1
H-NMR (DMSO-
d6)   δ  1.22  (t,  3H;  -OCH2CH3, J
 
 = 6.9 Hz),  4.37 (q,  2H;  -OCH2CH3  J  = 6.9 Hz),   7.44 - 8.20  (m, 4H; 
 
quinazolinone),  6.97,  7.87,  8.41 (m, 3H; H-4, H-5, H-6, pyridine  moiety). 
3-Ethoxycarbonyl-2-ethoxyquinazolin-4-one   13.  
 
 Compound 2 (0.01 mol) was heated under refluxed with 
ethyl chloroformate (0.01 mol) in 50 mL of dry pyridine for 4h. The excess solvent was distilled off and the 
solution was left to cool and then poured onto ice with stirring to obtain a crude product, which was filtered
 
 
off, thoroughly washed with cold water, dried and crystallized from benzene affording products 13 as white 
crystals;  m.p. 177-178 ºC;  yield 92 %.  Anal. for
 
 C13H14N2O4   (m.w. 262);  Found:  C, 59.65;  H, 5.39;  N, 
10.68;  Calcd: C, 59.54; H, 5.34; N, 10.69; IR υ  (cm-1) 1672, 1762 (2 C=O); MS: m/z (int. %)  [M+H]+  262 
(88.5);  
1
H-NMR (DMSO-d6) δ 1.19 (t, 3H, -OCH2CH3,  J = 7.4 Hz), 1.15 (t, 3H, CH3, COOCH2CH3), 4.24 
(q, 2H, CH2, COOCH2CH3), 4.34 (q,  2H;  -OCH2CH3,  J = 7.4 Hz), 7.43-8.17 (m, 4H, ArH). 
2-Ethoxy-4(3H)quinazolin-4-thione  14.   A solution of compound 2 and P2S5 (0.03 mol each) in dry xylene 
(50 mL) was boiled for 6
 
h. The reaction mixture was filtered while hot and then concentrated. The product 
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separated on cooling was crystallized from ethanol to give the product  14. Brown crystals of m.p. 137-138 
ºC; yield 65 %. Anal. for C10H10N2OS (m.w. 206); Found: C, 58.15; H, 4.81; N, 13.52; S, 15.53;  Calcd:  C, 
58.25;  H, 4.85;  N, 13.59;  S, 15,53;   IR  υ  (cm-1)  1319 (C=S), 1597 (C=N), 3137 (NH);  MS: m/z (int. %) 
[M+H]
+  206 (55.7); 
1
H-NMR (DMSO-d6) δ 1.19 (t, 3H, -OCH2CH3,  J = 7.4 Hz),  4.39 (q, 2H; -OCH2CH3, 
J = 7.4 Hz), 7.29-7.67 (m, 4H, ArH), 12.3 (br s, 1H, NH). 
4-Chloro-2-ethoxyquinazoline 15.    A solution of 2-ethoxy-4(3H)quinazolinone 1 (0.01 mol) in phosphorus 
oxychloride (20 mL) was heated on a water bath at 70 °C for 2 h. The reaction mixture was then cooled and 
diluted with ice/water and the resulting precipitate was collected by filtration and recrystallized from CHCl3 
chloroform giving product 15 as light brown crystals; m.p. 180-182 ºC; yield 85 %. Anal.
 
 For
  
C10H9N2OCl  
(m.w. 208.5); Found: C, 57.45; H, 4.31; N, 13.42; Cl, 17.00; Calcd: C, 57.55; H, 4.30;  N, 13.43; Cl, 17.02; 
IR  υ  (cm-1)  1622  (C=N);   MS: m/z  (int. %)  [M+H]+    208.5 (57.9); 1H-NMR  (DMSO-d6)  δ 1.19 (t, 3H, 
OCH2CH3,  J = 7.4 Hz), 4.19 (q,  2H;  -OCH2CH3, J = 7.4 Hz), 7.49-8.86 (m, 4H,  ArH). 
2-Ethoxyquinazolin-4-ylhydrazine  16.     An emulsion of product 15 (0.01mol) and hydrazine hydrate (0.05 
mol)  in benzene (15 mL) was stirred for 2 h.  The
 
benzene-insoluble gum obtained was treated and washed 
with water,
 
dried and crystallized from ethanol giving reddish brown
 
crystals of product 16. Yield 68 %;  m. 
p. 156-158 °C.  Anal.  for  C10H12N4O  (M. wt. 204);  Found:  C, 58.86; H, 5.78; N, 27.45;  Calcd:  C, 58.82;  
H, 5.88; N, 27.45;
 
 IR υ (cm-1) 1620 (C=N), 3160(NH), 3250, 3300 (NH2); MS: m/z  [M+H]
+
 204; 
1
H-NMR 
(DMSO-d6)  δ 1.18 (t, 3H, CH3   of  ethoxy J = 7.4 Hz), 4.17 (q, 2H, CH2 of  ethoxy  J = 7.4 Hz), 7.40 - 8.06 
(m, 4H, ArH), 8.65 (br. s, 3H, NH and NH2). 
4-(2-Ethoxyquinazolin-4-yl)thiosemicarbazide  17.   A mixture of the quinazoline 15 and thiosemicarbazide 
(0.01 mol each) was heated under reflux in acetic acid / fused sodium acetate (30 mL / 2 g) for 3 h. Pouring 
the solution onto ice/water left a white solid which was filtered, washed with water, dried and recrystallized 
from ethanol giving white crystals
 
 of compound  17;  yield 74 %;  m.p. 128 -130 ºC. Anal. for C11H13N5OS 
(m.wt. 263);  Found:  C, 53.38;  H, 5.19;  N, 28.39;  Calcd:  C, 53.44;  H, 5.26;  N, 28.34;  IR 
 υ (cm-1) 1381 
(C=S), 1620 (C=N), 3418, 3250 (NH and NH2).  MS: m/z [M+H]
+ 
 263
 
(77%). 
1
H-NMR (DMSO-d6) 
 δ 1.20 
(t, 3H; CH3 of ethoxy  J = 7.2 Hz), 4.15 (q, 2H; CH2 of ethoxy J = 7.2), 7.44-8.06(4d, 4H, ArH), 8.41 - 9.34 
(2 br. s, 4H, 2NH and NH2). 
Synthesis of Compounds 18a-c  
A mixture of compound 1 (0.01 mol) and the aminothiadiazole derivatives
 
 2-phenyl-5-aminothiadiazole, 2-
cinnamyl-5-aminothiadiazole  and  2-phthalimidomethyl-5-aminothiadiazole (0.01 mol)  was  heated  under 
reflux in boiling  acetic  acid / fused  sodium  acetate (30 mL / 2 g) for 3 h. 
 
The solution was poured into an 
ice / water mixture, stirred and left to settle down affording a white solid.    The resulting solid was filtered, 
washed, dried and finally recrystallized from  the proper solvent affording the derivatives   18a-c. 
5-[2-Ethoxy-quinazolone-3-yl]-2-phenylthiadiazole   18a.      Brown crystals from DMF;  m.p.  172-173 ºC; 
yield 85 %.  Anal.  for   C18H14N4O2 S (m.w. 350); 
  
Found:  C, 61.88;
 
 H, 4.04; N, 16.08; S, 9.17;  Calcd: C, 
61.71;  H, 4.00;  N, 16.00;
 
 S, 9.14.  IR υ (cm-1) 1630  (C=N), 1669  (C=O).   MS:  m/z (int. %) [M+H]+  350 
(78.0), 352 (31.1),  191 (100), 193 (23.7), 157 (4.4), 159 (0.1), 175 (49.5), 177 (9.7),  162 (38.2),  164 (3.6), 
130  (61.2),  132  (4.1),  103  (1.8),  105  (0.2),  78  (0.7),  80  (0.1);  
1
H-NMR  (DMSO-d6)  δ
  
1.22  (t, 3H; -
OCH2CH3, J
 
 = 7.1 Hz), 4.40 (q, 2H;  -OCH2CH3,  J  = 7.1 Hz),   7.41 - 7.94 (m, 5H, Ph-H),  7.44 - 8.20 (m, 
4H, quinazolinone). 
5-[2-Ethoxy-quinazolone-3-yl]-2-cinnamylthiadiazole  18b.     Brown  crystals  from  DMF;    m.p. 289-290 
ºC; yield 85 %. Anal.  for C20H16N4O2 S (m.w. 376); Found: C,  68.99;  H, 4.72;  N, 16.00;  S,  9.03;  Calcd:  
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C,  68.97;  H, 4.60;  N,  16.09;  S, 9.20. IR υ (cm-1) 1633  (C=N),  1689  (C=O).   MS:  m/z (int. %) [M+H]+  
376 (72.0),  378 (14.9), 191 (100), 193 (17.5),  188 (14.2), 190 (3.1), 175 (48.2), 177 (12.7), 157 (5.7),  159 
(0.2), 130 (67.1), 132 (1.8), 129 (0.8),  131 (0.2), 122 (1.3), 124 (0.1), 78 (0.6),  80 (0.1). 
1
H-NMR (DMSO-
d6)  δ  1.23  (t, 3H; -OCH2CH3,  J
 
 = 7.1 Hz),  4.43  (q,  2H;  -OCH2CH3,   J  = 7.1 Hz);  7.42- 8.20  (4d, 4H, 
quinazolinone), 7.35 - 7.45 (m, 5H,  Ph-H), 7.20, 7.47 (2d,  2H,  J = 15.8 Hz, olefinic-H). 
5-[2-Ethoxyquinazolone-3-yl]-2-phthalamidomethylthiadiazole    18c.   
 
Brown  crystals  from  DMF;   m.p. 
303-304 ºC;  yield 85 %.  Anal. for C21H15N5O4 S  (m.w. 433);  found:  C, 58.72; H, 3.66; N, 16.31; S, 7.42;  
Calcd: C, 58.20;  H, 3.46;  N, 16.17; S, 7.39. IR υ (cm-1) 1631 (C=N), 1670, 1727, 1776 (3xC=O).  MS: m/z 
(int. %) [M+H]+  433 (58.0), 435 (22.8), 245 (36.4), 247 (3.4), 191 (100), 193 (56.1), 186 (78.0), 188 (12.7),  
175  (30.1), 177  (8.1),  157 (3.2),  159  (0.1),  147  (8.3),  149  (0.3),  130 (48.3),  132 (6.4),  122 (4.5), 124 
(0.2),  78 (0.3),  80 (0.1);  
1
H-NMR  (DMSO-d6)   δ  1.21 (t,  3H;  -OCH2CH3,  J
 
 = 7.1 Hz),  4.48  (q, 2H;   
-OCH2CH3,   J  = 7.1 Hz),  5.16 (s, 2H; CH2,  phthalimidomethyl), 7.32 - 7.86 (m, 4H, quinazolinone), 7.94 
- 8.03 (m, 4H, phthalimido-H). 
  
Synthesis of Compounds 19a-c  
The quinazolinone thiadiazole derivative 18a-c was heated  under  reflux  with  formamide  (0.01 mol each) 
for 3 h. The mixture was  poured onto  ice/water  mixture with  stirring leaving a white  material to separate 
out and then begin to solidify forming gum.   This material was washed with water, filtered and crystallized 
from ethanol as off-white needles of 19a-c. 
5-[2-Amino-4-oxoquinazolin-3(4H)-yl]-2-phenylthiadiazole   19a.  Yield 73 %, m.p. 243-245 °C. Anal. for 
C18H14N4O2S (m.w. 350);  Found: C, 61.76; H, 4.04; N, 16.02; S, 9.17;  Calcd: C, 61.71; H, 4.00; N, 16.00; 
S, 9.14; IR υ (cm-1) 1669 (C=O), 1531 (C=N); 3330 (NH); 3444 (CH); MS: m/z (int. %) [M+H]+ 350 (72.3); 
1
H-NMR (DMSO-d6) δ 2.11 (s, 2H, NH2 ), 7.28-7.77 (m, 4H; quinazolinone), 7.41-7.93 (m, 5H; ph-H). 
5-[2-Amino-4-oxoquinazolin-3(4H)-yl]-2-cinnamylthiadiazole  19b.  Yield 78 %,   m.p. 262-263 °C.  Anal. 
for  C20H16N4O2S  (m.w. 376);  Found:  C, 63.87;  H, 4.27;  N, 14.91;  S, 8.53;  Calcd: C, 63.83; H, 4.26; N, 
14.89; S, 8.51; IR υ (cm-1) 1670 (C=O), 1529 (C=N); 3392 (NH); 3433 (CH); MS: m/z (int. %) [M+H]+ 376 
(78.3); 
1
H-NMR (DMSO-d6) δ 2.04 (s, NH, NH2), 7.20, 7.47 (2d,  2H, J = 15.8 Hz, olefinic-H), 7.34-7.44 
(m, 5H, Ph-H), 7.30-7.77 (m, 4 H, quinazolinone). 
2-{[5-(2-Amino-4-oxoquinazolin-3(4H)-yl)-1,3,4-thiadiazol-2-yl] methyl}-1H-isoindole-1,3(2H)-dione
 
 19c. 
Yield 68 %,  m.p. 272-273 °C. Anal.  for  C19H12N6O3S  (m.w. 404); 
 
Found: C, 56.49; H, 2.99; N, 20.83; S, 
7.95;  Calcd:  C, 56.44;  H, 2.97;  N, 20.79;  S, 7.92;  IR υ (cm-1) 1671, 1730, 1790  (3xC=O),  1528 (C=N); 
3389 (NH);  3443 (CH);  MS: m/z (int. %) [M+H]
+
 404 (78.3); 
1
H-NMR  (DMSO-d6)  δ  2.00 (s, 2H,  NH2), 
7.29-8.19 (m, 4H; ArH), 7.30-7.77 (m, 4 H, quinazolinone) . 
Synthesis of Compounds 20a-c 
Compound   19a-c  (0.01 mol) was dissolved in 50 mL of dry toluene and cooled to 15 °C.  To this solution 
was added drop wise an equimolar amount of chloroacetyl chloride with frequent stirring.  The temperature 
of the reaction was brought slowly to room temperature an then the solution was heated under reflux for 4h. 
The excess toluene was distilled off and the resultant precipitate was filtered,  washed  repeatedly  with  dry 
toluene, dried and crystallized from aqueous dioxane affording compounds 20a-c. 
2-Chloro-N-[3-(5-phenyl-1,3,4-thiadiazol-2-yl)-4-oxo-3,4-dihydroquinazolin-2-yl]acetamide 20a. White 
crystals from dioxane;  m.p. 163-164°C,
 
 yield 77 %.  Anal.  For  C18H12ClN5O2S  (m.w. 397.5);  Found: C, 
54.38;  H, 3.05;  Cl, 8.96;  N, 17.66;  S, 8.08;  Calcd: C, 54.34 ;  H, 3.02;  Cl, 8.93;  N, 17.61;  S, 8.05;  IR υ 
(cm
-1
) 3230 (N-H), 3023 (Ar-H), 2995 (CH2), 1668, 1699 (CO), 763 (CCl);  MS: m/z (int. %) [M+H]
+
 397.5 
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(68.4); 
1
H-NMR (DMSO-d6)  δ  4.41 (s, 2H, CH2Cl), 8.11 (s, 1H, NH), 7.38-7.93 (m, 4H, Ph-H) 7.21-8.19 
(m, 4H, quinazolinone). 
 
2-Chloro-N-(4-oxo-3-{5-[(E)-2-phenylethenyl]-1,3,4-thiadiazol-2-yl}-3,4-dihydroquinazolin-2-
yl)acetamide  20b.   White crystals from dioxane; m.p. 171-173°C, yield 81 %.  Anal. For  C20H14Cl N5O2S 
(m.w. 423.5);  Found: C, 56.71; H, 3.33; Cl, 8.40; N, 16.55; S, 7.58;  Calcd: C, 56.67 ; H, 3.31; Cl, 8.38; N, 
16.53; S, 7.56;  IR υ (cm-1) 3205 (N-H), 3010 (Ar-H), 2935 (CH2), 1666, 1694, (CO), 775 (CCl);    MS: m/z 
(int. %) [M+H]
+
 423.5 (73.4); 
1
H-NMR (DMSO-d6) δ 4.41 (s, 2H, CH2Cl),8.00 (s, 1H, NH), 7.20, 7.47 (2 d, 
2 H, olefin-H), 7.28-7.45 (m, 4H, cinnamyl moiety), 7.27-8.14 (m, 4H, quinazolinone). 
 
2-Chloro-N-(3-{5-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-1,3,4-thiadiazol-2-yl}-4-oxo-3,4- 
dihydroquinazolin-2-yl)acetamide 20c. White crystals from dioxane; m.p. 179-181°C, yield 73 %. Anal. for 
C21H13ClN6O4S  (m.w.  480.5);  Found:  C, 52.48; H, 2.74; Cl, 7.43; N, 14.57; S, 6.71;  Calcd: C, 52.44 ; H, 
2.71;  Cl, 7.39;  N, 14.48;  S, 6.66;  IR  υ  (cm-1)  3205 (N-H), 3010  (Ar-H), 2935 (CH2),  1666, 1694, 1776 
(CO), 775 (CCl);   MS: m/z (int. %) [M+H]
+
 480.5 (73.4); 
1
H-NMR (DMSO-d6) δ 4.60 (s, 2H, CH2Cl), 8.00 
(s, 1H, NH), 7.25-7.85 (m, 4H, quinazolinone), 7.96-8.03 (m, 4H, phthalimido moiety). 
2-Chloro-N-(2-ethoxy-4-oxoquinazolin-3(4H)-yl)acetamide  21.    Compound 3 (0.01 mol) was dissolved in 
50 mL of dry toluene and cooled to 15 °C.
       
 To this solution was added drop wise an equimolar amount of 
chloroacetyl chloride with frequent stirring.       The temperature of the reaction was
 
brought slowly
 
to room 
temperature and then the solution was
 
heated under reflux for 4
 
h.    The excess toluene was distilled off and 
the resultant precipitate was filtered,   washed repeatedly with dry toluene,  dried and then crystallized from 
aqueous dioxane as white crystals of compound 21,   m.p. 149-151
 
°C, yield 73 %. Anal. for C12H12Cl N3O3  
(m.w. 281.5); Found: C, 51.15; H, 4.26; N, 14.92; Cl, 12.61; Calcd: C, 51.22 ; H, 4.29; N, 14.99; Cl, 12.66; 
IR  υ  (cm-1)  3205 (N-H), 3010 (ArC-H), 2935 (CH2), 1666,  1694 (CO), 1568,
 
1328 (CN),
 
775 (CCl);  MS: 
m/z (int. %) [M+H]
+ 
281
 
(73.4); 
1
H-NMR (DMSO-d6) 
  δ  1.15 (t, 3H; OCH2CH3), 4.31 (s, 2H, CH2Cl), 4.43 
(q,
 
2H; OCH2CH3), 8.0 (s, 1H, NH), 7.28-8.20 (m, 4H, ArH). 
3-Chloroacetyl-2-ethoxyquinazolin-4-one   22.   
    
Compound 2 (0.01 mol) was  refluxed  with
 
 chloroacetyl 
chloride (0.01 mol) in 50 mL of dry pyridine for 4 h.    The excess solvent was distilled off and the solution 
was left to cool and then poured onto ice with frequent stirring till a crude product was obtained.  The latter 
was filtered off, thoroughly washed with cold water, dried and crystallized from ethanol affording brownish 
white crystals of derivative 8; m.p. 152-153 ºC; yield  85 %.
 
Anal. for
 
 C12H11N2O3Cl  (m.w. 266.5);  Found: 
C, 54.52; H, 5.69; N, 7.92; Cl, 13.32; Calcd: C, 54.54;  H, 5.68; N, 7.95; Cl, 13.28;  IR υ  (cm-1)  1668, 1717 
(2 C=O), 2823 (CH); MS: m/z (int. %) [M+H]
+
 266.5 (77.3); 
1
H-NMR (DMSO-d6) δ 1.2 (t, 3H, -OCH2CH3, 
J = 7.4 Hz), 4.36 (q, 2H; -OCH2CH3, J = 7.4 Hz), 4.29 (d, 2H, CH2Cl), 7.45-8.20 (m, 4H, ArH). 
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